Approval · Notice of Compliance 4931 · 1995
ACTINAC: Notice of Compliance 4931
Issued October 10, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4931
- Date
- October 10, 1995
- Company
- Hoechst Roussel Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revised product monograph
- Therapeutic class
- Topical anti-acne
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACTINAC | Not yet assigned | — |
Medicinal ingredients
- BUTOXYETHYLNICOTINATE 24 MG per G
- HYDROCORTISONE ACETATE 40 MG per G
- CHLORAMPHENICOL 40 MG per G
- ALLANTOIN 24 MG per G
- SULFUR 320 MG per G